Metra Biosystems, Abbott deal

The companies entered into a non-exclusive development and marketing collaboration to commercialize MTRA's biochemical markers on a worldwide basis. Abbott received the right to develop and market automated tests for metabolic bone and joint diseases based upon MTRA's technologies. ...